TACE
Clinical trials for TACE explained in plain language.
Never miss a new study
Get alerted when new TACE trials appear
Sign up with your email to follow new studies for TACE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer trial hopes TACE boosts Immunotherapy's punch
Disease control Not yet recruitingThis study tests whether adding a targeted chemoembolization procedure (TACE) to standard immunotherapy can improve outcomes for people with advanced liver cancer that cannot be removed by surgery. About 90 participants will receive both treatments to see if the combination shrin…
Matched conditions: TACE
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Virus and chemo combo takes on hard-to-treat head and neck cancer
Disease control Not yet recruitingThis study tests a treatment that combines a modified virus (H101) with a procedure called TACE (chemoembolization) for people with recurrent or metastatic head and neck cancer that hasn't responded to at least two prior treatments. The goal is to kill tumor cells and activate th…
Matched conditions: TACE
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
AI reads liver cancer slides to personalize Post-Surgery care
Knowledge-focused Not yet recruitingThis study aims to build an AI tool that analyzes standard tissue images from liver cancer patients after surgery. The goal is to predict who will benefit from additional treatments like chemotherapy or targeted drugs. Researchers will use data from 1,000 patients across multiple…
Matched conditions: TACE
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC